STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma Contributor Leukemia Behind the paper STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma Cosimo Lobello Dec 01, 2020
